| Cash Flow | 2025-10-31 | 2025-07-31 |
|---|---|---|
| Net loss | -58,611 | -25,826 |
| Depreciation and amortization | 4,401 | 2,028 |
| Loss on disposal of property and equipment | -560 | -280 |
| Reserve for lost medical supplies | - | 412 |
| Reserve for lost equipment and supplies | 901 | - |
| Provision for uncollectible accounts receivable | 1,150 | 613 |
| Amortization of debt discounts and issuance costs | 937 | 469 |
| Share-based compensation expense | 13,232 | 4,579 |
| Non-cash lease expense | 148 | 61 |
| Change in fair value of warrant liabilities | -2,065 | -2,909 |
| Disposable medical equipment supplies | -596 | -460 |
| Prepaid expenses and other current assets | -953 | -140 |
| Accounts receivable | 3,482 | 1,777 |
| Accounts payable | -2,372 | -2,896 |
| Accrued liabilities | 520 | -860 |
| Operating lease liabilities | -313 | -138 |
| Other long-term assets | -20 | -10 |
| Net cash used in operating activities | -44,617 | -26,274 |
| Purchases of property and equipment | 15,431 | 8,166 |
| Deposits for medical rental equipment | 338 | 103 |
| Refund of deposits for medical rental equipment | 117 | 37 |
| Net cash used in investing activities | -15,652 | -8,232 |
| Payments of ipo offering costs | - | 1,875 |
| Payment of equity issuance costs | 1,902 | - |
| Net cash provided by (used in) financing activities | -1,902 | -1,875 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -62,171 | -36,381 |
| Cash and cash equivalents at beginning of period | 237,929 | - |
| Cash and cash equivalents at end of period | 175,758 | - |
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)